Education
About Us
Working with TipRanks
Follow Us
Venus Remedies Limited (IN:VENUSREM)
:VENUSREM
VENUSREM Stock Chart & Stats
₹823.10
-₹3.85(-1.26%)
At close: 4:00 PM EST
₹823.10
-₹3.85(-1.26%)
Day’s Range― - ―
52-Week Range₹272.20 - ₹839.95
Previous CloseN/A
Volume28.34K
Average Volume (3M)2.33K
Market Cap
₹10.66B
Enterprise Value₹2.38B
Total Cash (Recent Filing)₹1.56B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)14.6
Beta0.94
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)15.06
Shares Outstanding13,366,988
10 Day Avg. Volume2,529
30 Day Avg. Volume2,330
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.75
Price to Sales (P/S)0.65
P/FCF Ratio5.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Venus Remedies Limited News
VENUSREM FAQ
What was Venus Remedies Limited’s price range in the past 12 months?
Venus Remedies Limited lowest stock price was ₹272.20 and its highest was ₹839.95 in the past 12 months.
What is Venus Remedies Limited’s market cap?
Venus Remedies Limited’s market cap is ₹10.66B.
When is Venus Remedies Limited’s upcoming earnings report date?
Venus Remedies Limited’s upcoming earnings report date is Feb 18, 2026 which is in 61 days.
How were Venus Remedies Limited’s earnings last quarter?
Venus Remedies Limited released its earnings results on Nov 10, 2025. The company reported ₹15.06 earnings per share for the quarter, beating the consensus estimate of N/A by ₹15.06.
Is Venus Remedies Limited overvalued?
According to Wall Street analysts Venus Remedies Limited’s price is currently Overvalued.
Does Venus Remedies Limited pay dividends?
Venus Remedies Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of N/A. See more information on Venus Remedies Limited dividends here
What is Venus Remedies Limited’s EPS estimate?
Venus Remedies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Venus Remedies Limited have?
Venus Remedies Limited has 13,366,988 shares outstanding.
What happened to Venus Remedies Limited’s price movement after its last earnings report?
Venus Remedies Limited reported an EPS of ₹15.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.512%.
Which hedge fund is a major shareholder of Venus Remedies Limited?
Currently, no hedge funds are holding shares in IN:VENUSREM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Venus Remedies Limited
Venus Remedies Limited (VENUSREM) is a leading pharmaceutical company based in India, specializing in the development, manufacturing, and marketing of a diverse range of generic and innovative pharmaceutical products. The company operates in various sectors, including injectables, oral solids, and advanced drug delivery systems, with a strong focus on providing high-quality, cost-effective therapeutic solutions across multiple therapeutic areas such as oncology, cardiology, and infectious diseases. Venus Remedies is also engaged in contract manufacturing and has established a global presence through exports to numerous countries.
Technical Analysis
Ind-Swift Laboratories Ltd.
―
Kilitch Drugs (India) Limited
―
Medicamen Biotech Limited
―
Nectar Lifesciences Ltd.
―
Zim Laboratories Ltd.
―